Literature DB >> 33477867

An Analysis of Vertebral Body Growth after Proton Beam Therapy for Pediatric Cancer.

Keiichiro Baba1, Masashi Mizumoto1, Yoshiko Oshiro1,2, Shosei Shimizu1, Masatoshi Nakamura1, Yuichi Hiroshima1, Takashi Iizumi1, Takashi Saito1, Haruko Numajiri1, Kei Nakai1, Hitoshi Ishikawa1,3, Toshiyuki Okumura1, Kazushi Maruo4, Hideyuki Sakurai1.   

Abstract

Impairment of bone growth after radiotherapy for pediatric bone cancer is a well-known adverse event. However, there is limited understanding of the relationship between bone growth and irradiation dose. In this study, we retrospectively analyzed bone growth impairment after proton beam therapy for pediatric cancer. A total of 353 vertebral bodies in 23 patients under 12 years old who received proton beam therapy were evaluated. Compared to the non-irradiated vertebral body growth rate, the irradiated vertebral body rate (%/year) was significantly lower: 77.2%, 57.6%, 40.8%, 26.4%, and 14.1% at 10, 20, 30, 40, and 50 Gy (RBE) irradiation, respectively. In multivariate analysis, radiation dose was the only factor correlated with vertebral body growth. Age, gender, and vertebral body site were not significant factors. These results suggest that the growth rate of the vertebral body is dose-dependent and decreases even at a low irradiated dose. This is the first report to show that proton beam therapy has the same growth inhibitory effect as photon radiotherapy within the irradiated field.

Entities:  

Keywords:  bone; child; pediatric; proton beam therapy; vertebral body

Year:  2021        PMID: 33477867      PMCID: PMC7832908          DOI: 10.3390/cancers13020349

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  38 in total

1.  Results of proton beam therapy without concurrent chemotherapy for patients with unresectable stage III non-small cell lung cancer.

Authors:  Yoshiko Oshiro; Masashi Mizumoto; Toshiyuki Okumura; Takayuki Hashimoto; Nobuyoshi Fukumitsu; Ayako Ohkawa; Ayae Kanemoto; Haruko Hashii; Toshiki Ohno; Takeji Sakae; Koji Tsuboi; Hideyuki Sakurai
Journal:  J Thorac Oncol       Date:  2012-02       Impact factor: 15.609

2.  Height after photon craniospinal irradiation in pediatric patients treated for central nervous system embryonal tumors.

Authors:  Masashi Mizumoto; Yoshiko Oshiro; Haitao Pan; Fang Wang; Sue C Kaste; Amar Gajjar; Wassim Chemaitilly; Thomas E Merchant
Journal:  Pediatr Blood Cancer       Date:  2020-07-26       Impact factor: 3.167

3.  Cost effectiveness of proton versus photon radiation therapy with respect to the risk of growth hormone deficiency in children.

Authors:  Raymond Mailhot Vega; Jane Kim; Abby Hollander; Jona Hattangadi-Gluth; Jeff Michalski; Nancy J Tarbell; Torunn I Yock; Marc Bussiere; Shannon M MacDonald
Journal:  Cancer       Date:  2015-01-29       Impact factor: 6.860

4.  Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy.

Authors:  Roshan V Sethi; Helen A Shih; Beow Y Yeap; Kent W Mouw; Robert Petersen; David Y Kim; John E Munzenrider; Eric Grabowski; Carlos Rodriguez-Galindo; Torunn I Yock; Nancy J Tarbell; Karen J Marcus; Shizuo Mukai; Shannon M MacDonald
Journal:  Cancer       Date:  2013-10-02       Impact factor: 6.860

5.  A comparative study on the risks of radiogenic second cancers and cardiac mortality in a set of pediatric medulloblastoma patients treated with photon or proton craniospinal irradiation.

Authors:  Rui Zhang; Rebecca M Howell; Phillip J Taddei; Annelise Giebeler; Anita Mahajan; Wayne D Newhauser
Journal:  Radiother Oncol       Date:  2014-08-12       Impact factor: 6.280

6.  Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma.

Authors:  N Patrik Brodin; Per Munck Af Rosenschöld; Marianne C Aznar; Anne Kiil-Berthelsen; Ivan R Vogelius; Per Nilsson; Birgitta Lannering; Thomas Björk-Eriksson
Journal:  Acta Oncol       Date:  2011-08       Impact factor: 4.089

7.  Stature loss following treatment for Wilms tumor.

Authors:  C J Hogeboom; S C Grosser; K A Guthrie; P R Thomas; G J D'Angio; N E Breslow
Journal:  Med Pediatr Oncol       Date:  2001-02

8.  Stature loss following skeletal irradiation for childhood cancer.

Authors:  J H Silber; P S Littman; A T Meadows
Journal:  J Clin Oncol       Date:  1990-02       Impact factor: 44.544

9.  Cost effectiveness of proton therapy compared with photon therapy in the management of pediatric medulloblastoma.

Authors:  Raymond B Mailhot Vega; Jane Kim; Marc Bussière; Jona Hattangadi; Abby Hollander; Jeff Michalski; Nancy J Tarbell; Torunn Yock; Shannon M MacDonald
Journal:  Cancer       Date:  2013-09-16       Impact factor: 6.860

Review 10.  Proton Beam Therapy for Pediatric Brain Tumor.

Authors:  Masashi Mizumoto; Yoshiko Oshiro; Tetsuya Yamamoto; Hidehiro Kohzuki; Hideyuki Sakurai
Journal:  Neurol Med Chir (Tokyo)       Date:  2017-06-09       Impact factor: 1.742

View more
  3 in total

1.  A Case Report of Radiotherapy for Skull Lesions of Langerhans Cell Histiocytosis With Dural Invasion.

Authors:  Yuichi Hiroshima; Yoshio Tamaki; Takuya Sawada; Motohiro Murakami; Toshiki Ishida; Takashi Saitoh; Hiroshi Kojima; Toshiyuki Okumura; Hideyuki Sakurai
Journal:  Cancer Diagn Progn       Date:  2022-03-03

2.  The comparison of acute toxicities associated with craniospinal irradiation between photon beam therapy and proton beam therapy in children with brain tumors.

Authors:  Suguru Uemura; Yusuke Demizu; Daiichiro Hasegawa; Tomoko Fujikawa; Shotaro Inoue; Akihiro Nishimura; Ryunosuke Tojyo; Sayaka Nakamura; Aiko Kozaki; Atsuro Saito; Kenji Kishimoto; Toshiaki Ishida; Takeshi Mori; Jyunji Koyama; Atsufumi Kawamura; Yoshinobu Akasaka; Makiko Yoshida; Nobuyoshi Fukumitsu; Toshinori Soejima; Yoshiyuki Kosaka
Journal:  Cancer Med       Date:  2022-02-09       Impact factor: 4.452

3.  Safety and Efficacy of Carbon-Ion Radiotherapy for Elderly Patients with High-Risk Prostate Cancer.

Authors:  Yuichi Hiroshima; Hitoshi Ishikawa; Yuma Iwai; Masaru Wakatsuki; Takanobu Utsumi; Hiroyoshi Suzuki; Koichiro Akakura; Masaoki Harada; Hideyuki Sakurai; Tomohiko Ichikawa; Hiroshi Tsuji
Journal:  Cancers (Basel)       Date:  2022-08-19       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.